Coloplast A/S (CLPBY) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Humlebæk, Denmark. The current CEO is Lars Soren Rasmussen.
CLPBY has IPO date of 2014-01-13, 16,741 full-time employees, listed on the Other OTC, a market capitalization of $15.22B.
Coloplast A/S is a Danish healthcare company founded in 1954 that develops and markets intimate healthcare products and services globally, with significant operations in the United States, United Kingdom, France, and Denmark. The company operates through three core segments: Chronic Care, which includes ostomy and continence care products such as SenSura and SpeediCath; Wound & Skin Care, featuring branded solutions like Biatain Silicone and Comfeel dressings; and Interventional Urology, offering products for surgical treatment of urological and gynecological conditions. Coloplast's product portfolio addresses chronic conditions including ostomy management, urinary incontinence, wound care, and skin health through both therapeutic devices and accessories. Headquartered in Humlebæk, Denmark, the company serves patients and healthcare providers worldwide with innovative solutions for conditions such as urinary stone disease, benign prostate hyperplasia, and erectile dysfunction.
